Although the precise mechanisms by which APOL1 facilitates kidney disease progression have not been fully elucidated, it is believed that these variants directly affect the function and structure of kidney parenchymal cells and may exacerbate tissue inflammation, thereby influencing the severity of LN. This evidence concerns the gene APOL1 and lobular neoplasia.